A Retrospective, Multi Centre, Non-Interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Post Stroke Patients With Hypertension.

AstraZeneca1 site in 1 country1,000 target enrollmentMay 2008

ConditionsHypertension

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Hypertension
Sponsor: AstraZeneca
Enrollment: 1000
Locations: 1
Primary Endpoint: Attainment rate to the target blood pressure
Status: Completed
Last Updated: 16 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors that affect BP control by examining retrospective medical records of hypertension patients recovering from stroke, among outpatients coming to the Neurology Department in 10 university hospitals nationwide.

Registry

clinicaltrials.gov

Start Date

May 2008

End Date

July 2008

Last Updated

16 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

AstraZeneca

Eligibility Criteria

Inclusion Criteria

•Patients had been hospitalized as a acute stroke in 2006
•Patient with history of stroke receiving hypertension medication during at least 1 year.

Exclusion Criteria

•Secondary hypertension patients
•Patients not receiving hypertension medication

Outcomes

Primary Outcomes

Attainment rate to the target blood pressure

Time Frame: After collecting all Patient Record Form.

Secondary Outcomes

Dropout rate will be estimated during the follow-up period after the hypertension treatment. Attainment to the target blood pressure will be investigated according to concomitant diseases.(After collecting all Patient Record Form.)
Change in DBP/SBP value during the follow-up period will be addressed. Change in the DBP/SBP value will be investigated according to the risk factors and concurrent disease.(After collecting all Patient Record Form.)